UK Badger Culls Slammed

Government-commissioned analyses obtained by the media suggest that the UK badger culls that began last year were ineffective and inhumane.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, PETER TRIMMINGThe UK badger culls that began August 2013 have failed to limit the spread of tuberculosis (TB) in cattle and were not conducted humanely, according to government-commissioned analyses released today (February 28). The Department for Environment, Food and Rural Affairs (DEFRA) green-lighted the culls in two counties last year—despite public protest—in an effort to lower levels of bovine TB, which has been devastating UK cattle farms for years, and which badgers are known to transmit.

According to BBC News, the documents showed that hired marksmen only killed about 50 percent of the badgers during the first six weeks of the culls, and the analyses revealed that the approach—shooting the badgers at night—may have left some animals injured such that they did not immediately die.

“I hope this will lead to the Secretary of State . . . to focus on other ways of eradicating TB in cattle,” Rosie Woodroffe, a senior research fellow at the Zoological Society of London, told BBC News.

According to The Guardian, “The revelations are the most damaging yet and will make it challenging for ministers to justify their aim of rolling out further culls across the country.”

A DEFRA spokesperson told the BBC that the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies